Eddie Hjerpe

Vice President at Great Point Partners

๐Ÿ“ Greenwich, Connecticut, United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 1 investments๐Ÿ“… 7 years investing๐Ÿ—“ Last invested Feb 2019
Angel investor๐ŸŒ United States
1
Total investments
0
Early stage
0
Mid stage
1
Late stage
7y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Feb 2019
MaSTherCell is a dynamic and global Contract Development and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to cell therapy organizations and speed up the arrival of their therapies onto the market. MaSTherCell is present in Europe (Gosselies, Belgium) with two plants and in the US (Houston, Texas). At the heart of MaSTherCell is a team of more than 200 highly dedicated experts combining strong experience in cGMP cell therapy manufacturing with a technology-focused approach and a substantial knowledge of the industry. From technology selection to business modeling, GMP manufacturing, process development, quality management, and analytical assay development, MaSTherCell's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients. For more information, visit www.masthercell.com.
late stageBiotechnology
Experience ยท 1 entries
All (1)
Investments (1)
Board (1)
2019
Board Member
Feb 2019
MaSTherCell is a dynamic and global Contract Development and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to cell therapy organizations and speed up the arrival of their therapies onto the market. MaSTherCell is present in Europe (Gosselies, Belgium) with two plants and in the US (Houston, Texas). At the heart of MaSTherCell is a team of more than 200 highly dedicated experts combining strong experience in cGMP cell therapy manufacturing with a technology-focused approach and a substantial knowledge of the industry. From technology selection to business modeling, GMP manufacturing, process development, quality management, and analytical assay development, MaSTherCell's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients. For more information, visit www.masthercell.com.
late stageBiotechnology